| Primary |
| Bipolar Disorder |
58.3% |
| Affective Disorder |
16.7% |
| Intermittent Explosive Disorder |
8.3% |
| Major Depression |
8.3% |
| Psychotic Disorder |
8.3% |
|
| Therapeutic Agent Toxicity |
12.5% |
| Tremor |
12.5% |
| Vomiting |
12.5% |
| Abnormal Behaviour |
6.3% |
| Asthenia |
6.3% |
| Blood Creatinine Increased |
6.3% |
| Medication Error |
6.3% |
| Mental Status Changes |
6.3% |
| Myoclonic Epilepsy |
6.3% |
| Nephrogenic Diabetes Insipidus |
6.3% |
| Sinus Bradycardia |
6.3% |
| Speech Disorder |
6.3% |
| Tonsillitis Streptococcal |
6.3% |
|
| Secondary |
| Schizoaffective Disorder |
59.1% |
| Product Used For Unknown Indication |
16.9% |
| Bipolar Disorder |
8.3% |
| Drug Use For Unknown Indication |
5.2% |
| Psychotic Disorder |
2.5% |
| Bipolar I Disorder |
1.8% |
| Schizophrenia |
0.9% |
| Testicular Malignant Teratoma Stage Iii |
0.9% |
| Dysmenorrhoea |
0.6% |
| Hyperthyroidism |
0.6% |
| Insomnia |
0.6% |
| Antidepressant Therapy |
0.3% |
| Back Pain |
0.3% |
| Diabetes Mellitus |
0.3% |
| Intermittent Explosive Disorder |
0.3% |
| Mania |
0.3% |
| Pain |
0.3% |
| Sleep Disorder |
0.3% |
| Thyroid Disorder |
0.3% |
|
| Hypertension |
14.5% |
| Cardiac Hypertrophy |
10.9% |
| Dyspnoea |
10.9% |
| Humerus Fracture |
7.3% |
| Toxicity To Various Agents |
7.3% |
| Myocardial Infarction |
5.5% |
| Renal Failure Chronic |
5.5% |
| Completed Suicide |
3.6% |
| Constipation |
3.6% |
| Lacunar Infarction |
3.6% |
| Metrorrhagia |
3.6% |
| Neuroleptic Malignant Syndrome |
3.6% |
| Organ Failure |
3.6% |
| Pyrexia |
3.6% |
| Therapeutic Agent Toxicity |
3.6% |
| Agitation |
1.8% |
| Blood Creatinine Increased |
1.8% |
| Continuous Haemodiafiltration |
1.8% |
| Depressed Level Of Consciousness |
1.8% |
| Diabetes Insipidus |
1.8% |
|
| Concomitant |
| Bipolar Disorder |
22.4% |
| Product Used For Unknown Indication |
15.5% |
| Anxiety |
8.6% |
| Post-traumatic Stress Disorder |
7.9% |
| Depression |
7.2% |
| Cardiovascular Disorder |
4.9% |
| Schizophrenia |
3.6% |
| Schizoaffective Disorder |
3.3% |
| Affective Disorder |
3.0% |
| Mood Swings |
2.6% |
| Panic Disorder |
2.6% |
| Bipolar I Disorder |
2.3% |
| Diabetes Mellitus |
2.3% |
| Sleep Disorder |
2.3% |
| Abdominal Discomfort |
2.0% |
| Arthralgia |
2.0% |
| Blood Pressure Abnormal |
2.0% |
| Contraception |
2.0% |
| Pain |
2.0% |
| Acne |
1.6% |
|
| Weight Increased |
18.5% |
| Malaise |
11.1% |
| Nausea |
7.4% |
| Drug Dose Omission |
5.6% |
| Drug Interaction |
5.6% |
| Vitreous Detachment |
5.6% |
| Aggression |
3.7% |
| Heart Rate Decreased |
3.7% |
| Hyperlipidaemia |
3.7% |
| Insomnia |
3.7% |
| Mental Status Changes |
3.7% |
| Osteonecrosis |
3.7% |
| Product Quality Issue |
3.7% |
| Rash |
3.7% |
| Serotonin Syndrome |
3.7% |
| Tremor |
3.7% |
| Vomiting |
3.7% |
| Anxiety |
1.9% |
| Atonic Urinary Bladder |
1.9% |
| Balanitis |
1.9% |
|
| Interacting |
| Schizophrenia |
21.4% |
| Bipolar Disorder |
14.3% |
| Constipation |
14.3% |
| Hypertension |
14.3% |
| Anxiety |
7.1% |
| Psychotic Disorder |
7.1% |
| Schizoaffective Disorder |
7.1% |
| Schizophrenia, Paranoid Type |
7.1% |
| Smoking Cessation Therapy |
7.1% |
|
| Renal Failure Acute |
50.0% |
| Restlessness |
25.0% |
| Toxicity To Various Agents |
25.0% |
|
